For both normal and senescent A549 cells, inoculation with anti-LUNX antibody in the presence of NK cells significantly reduced the tumor volume compared to inoculation with anti-LUNX antibody alone, which suggested that ADCC-mediated by NK cells also contributed to tumor rejection in vivo (Fig. 6K, L). Here, BPIFA1 is linked to neoplasm.